Silencing of ASC in Cutaneous Squamous Cell Carcinoma

Katharina Meier1, Stefan K Drexler2,3, Franziska C Eberle1

  • 1Department of Dermatology, University of Tuebingen, Tuebingen, Germany.

Plos One
|October 22, 2016
PubMed

Insights

Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) acts as a tumor suppressor in skin cancer. Epigenetic silencing of ASC impairs immune activation, but its restoration reactivates inflammasomes.

Area of Science:

  • Immunology
  • Oncology
  • Epigenetics

Background:

  • Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is crucial for inflammasome activation and cytokine secretion.
  • ASC also functions as a tumor suppressor by inducing apoptosis, a function lost in many cancers.
  • The role of ASC in cutaneous squamous cell carcinoma (SCC) requires further investigation.

Purpose of the Study:

  • To investigate the clinical significance of ASC in human cutaneous squamous cell carcinoma (SCC).
  • To explore the relationship between ASC expression, tumor dedifferentiation, and metastatic potential in SCC.
  • To elucidate the epigenetic mechanisms, specifically promoter methylation, that regulate ASC expression and inflammasome function in SCC.

Main Methods:

  • Immunohistochemistry was used to evaluate ASC expression in non-metastatic and metastatic SCC.
  • Methylation-specific PCR was employed to detect ASC promoter methylation.
  • Demethylating agents were used to restore ASC expression and assess inflammasome activation (AIM2, NLRP3) in methylated cell lines.

Main Results:

  • ASC expression in SCC correlated with the degree of dedifferentiation but not with metastatic potential.
  • ASC silencing via promoter-specific methylation was observed, leading to impaired inflammasome function.
  • Restoration of ASC expression using demethylating agents reactivated AIM2 and NLRP3 inflammasome activation.

Conclusions:

  • ASC plays a dual role in SCC, acting as a tumor suppressor while its loss is linked to pro-tumorigenic inflammation.
  • Epigenetic silencing of ASC by promoter methylation is a key mechanism contributing to its loss in SCC.
  • Restoring ASC expression can reactivate innate immune pathways, offering potential therapeutic avenues for SCC.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K